ERVW-1 and colorectal neoplasm: Furthermore, the MelARV study showed that the adenovirus-vectored vaccine encoding the MelARV Gag and the mutated Env, in combination with the immune checkpoint inhibitor, anti-PD-1 antibody, could eradicate established colorectal tumours in mice [25].